Hostname: page-component-84b7d79bbc-2l2gl Total loading time: 0 Render date: 2024-07-27T18:34:09.296Z Has data issue: false hasContentIssue false
  • English
  • Français

Intraneuronal Neurofibrillary Tangles Isolated from Alzheimer’ Disease Affected Brains Visualized by Vertical Platinum-Carbon Replication for TEM

Published online by Cambridge University Press:  02 July 2020

G.C. Ruben
G.C. Ruben*
Affiliation:
Department of Biological Sciences, Dartmouth College, Hanover, NH03755-1404
Get access

Extract

Neurofibrillary tangles (NFT) occur with high frequency in brains of patients with Alzheimer' disease (AD). The frequency of NFT directly correlates with the degree of dementia. Extra cellular plaque core amyloid also occurs in high frequently in AD brains when few intraneuronal NFT are present, these individuals are not demented.

The microtubule associated protein (MAP) tau is recognized as the principal constituent in paired helical filaments (PHF) and NFT. NFT contain PHF, amorphous structures containing tau, and a triple-stranded left-hand helical ˜2.1 nm filament similar to tau polymer which has been identified in isolated tangles. Tau is located in nerve cell axons and associates with and stabilizes the microtubules required for axonal transport. Sequestration of tau into tangles and its removal from microtubules not only compromises axonal transport but cripples synaptic communication between nerve cells.

NFT were isolated in the absence of detergent so these gel-like structures (Fig. 1) could be studied at the molecular level.

Type
Application of Novel Microscopic Approaches To Cellular Damage and Response
Information
Microscopy and Microanalysis , Volume 3 , Issue S2: Proceedings: Microscopy & Microanalysis '97, Microscopy Society of America 55th Annual Meeting, Microbeam Analysis Society 31st Annual Meeting, Histochemical Society 48th Annual Meeting, Cleveland, Ohio, August 10-14, 1997 , August 1997 , pp. 47 - 48
Copyright
Copyright © Microscopy Society of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Barcikowska, M.et al., Acta Neuropathol. (Bert.), 78(1989)225; Crystal, H.et al., Neurology 38(1988)1682-1687; Dickson, D.W. & Yen, S.C., Neurobiol. of Aging 10(1989)402.10.1007/BF00687751CrossRefGoogle Scholar
2.Grundke-Iqbal, I.et al., J. Biol. Chem., 261(1986)6084; Jakes, R.et al., EMBO J., 10(1991) 2725; Goedert, M. et al., Neuron, 8(1992)159.Google Scholar
3.Bancher, C.et al., Brain Research, 477(1989)90; Köpke, E.et al., J. Biol. Chem., 268(1993)24374; Ruben, G.C.et al., J. Biol. Chem., 266(1991)22019; Ibid, Brain Research, 590(1992)164; Ibid., Brain Research, 602(1993)1.10.1016/0006-8993(89)91396-6CrossRefGoogle Scholar
4.Iqbal, K.et al., Acta Neuropathol.(Berl.) 62 (1984) 167;10.1007/BF00691849CrossRefGoogle Scholar
5.Ruben, G.C., JEMT, 13(1989)335; Ibid. et al., Brain Research, 590(1992)164Google Scholar
6.Ruben, G.C.et al., Brain Research, 675(1995)1.10.1016/0006-8993(94)01437-MCrossRefGoogle Scholar
7.Kidd, M., Nature 197 (1963) 192.10.1038/197192b0CrossRefGoogle Scholar
8. Thanks to Dartmouth's Rippel EM center for the use of the Balzers 300 and the JEM lOOcx TEM.Google Scholar